Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Why Merck (MRK) Stock Is Down Today

None

Merck (MRK) is down 3.8% today. Here is some analysis on what might have caused this price movement. ([finance.yahoo.com](https://finance.yahoo.com/quote/MRK/?s=panabee&utm_source=openai))

Analysis: The most likely catalyst is Merck’s decision to discontinue the BELLWAVE clinical development program for nemtabrutinib after a review found that, in one Phase 3 study, the benefits may not outweigh the risks. Investors often treat the loss of a late-stage oncology or hematology program as a pipeline setback, especially for a large drugmaker working to broaden growth beyond its biggest products. ([merck.com](https://www.merck.com/news/merck-announces-update-on-bellwave-clinical-development-program-evaluating-nemtabrutinib/?utm_source=openai))

Details:

  • Merck announced on November 17, 2026 that it is ending development of nemtabrutinib, an investigational BTK inhibitor being studied in chronic lymphocytic leukemia, small lymphocytic leukemia, and other blood cancers. ([merck.com](https://www.merck.com/news/merck-announces-update-on-bellwave-clinical-development-program-evaluating-nemtabrutinib/?utm_source=openai))
  • The company said it is stopping the Phase 3 BELLWAVE-011 trial after an external monitoring review suggested the treatment’s benefits might not outweigh its risks, and Merck then expanded that decision to the broader BELLWAVE program. ([merck.com](https://www.merck.com/news/merck-announces-update-on-bellwave-clinical-development-program-evaluating-nemtabrutinib/?utm_source=openai))
  • The broader shutdown includes other Phase 3 studies, BELLWAVE-008 and BELLWAVE-010, which makes the update more meaningful than a single-trial adjustment. ([merck.com](https://www.merck.com/news/merck-announces-update-on-bellwave-clinical-development-program-evaluating-nemtabrutinib/?utm_source=openai))
  • This appears to be a pipeline-driven selloff rather than a fresh earnings issue, as Merck’s latest quarterly materials had recently highlighted revenue growth and ongoing pipeline activity before this setback. ([merck.com](https://www.merck.com/news/merck-co-inc-rahway-n-j-usa-announces-third-quarter-2026-financial-results-highlights-multiple-milestones-advancing-broad-diverse-pipeline/?utm_source=openai))
  • Sources:

    Merck, SEC, Yahoo Finance

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $MRK Insider Trading Activity

    MRK Insider Trades

    $MRK insiders have traded $MRK stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

    Here’s a breakdown of recent trading of $MRK stock by insiders over the last 6 months:

    • RICHARD R. DELUCA (EVP&Pres, Merck Animal Heallth) has made 0 purchases and 9 sales selling 109,555 shares for an estimated $15,343,016.
    • JENNIFER ZACHARY (EVP, General Counsel) sold 80,315 shares for an estimated $10,718,494
    • DAVID MICHAEL WILLIAMS (EVP,Chief Info&Digital Officer) has made 0 purchases and 3 sales selling 52,847 shares for an estimated $6,805,145.
    • CHIRFI GUINDO (EVP, Access, Policy & Comms) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $3,315,000.
    • DAVID R. MARALDO (EVP & Pres. MMD) has made 0 purchases and 3 sales selling 18,706 shares for an estimated $2,407,797.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive MRK Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $MRK Hedge Fund Activity

    We have seen 1,898 institutional investors add shares of $MRK stock to their portfolio, and 1,825 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $MRK Government Contracts

    We have seen $3,556,369 of award payments to $MRK over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $MRK Congressional Stock Trading

    Members of Congress have traded $MRK stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $MRK stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $MRK Analyst Ratings

    Wall Street analysts have issued reports on $MRK in the last several months. We have seen 14 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • JP Morgan issued a "Overweight" rating on 10/30/2026
    • Guggenheim issued a "Buy" rating on 10/30/2026
    • Barclays issued a "Overweight" rating on 10/26/2026
    • Morgan Stanley issued a "Overweight" rating on 10/07/2026
    • Scotiabank issued a "Sector Outperform" rating on 09/29/2026
    • HSBC issued a "Buy" rating on 09/10/2026
    • Leerink Partners issued a "Outperform" rating on 09/09/2026

    To track analyst ratings and price targets for $MRK, check out Quiver Quantitative's $MRK forecast page.

    $MRK Price Targets

    Multiple analysts have issued price targets for $MRK recently. We have seen 20 analysts offer price targets for $MRK in the last 6 months, with a median target of $170.0.

    Here are some recent targets:

    • Ilya Zubkov from Freedom Broker set a target price of $140.0 on 11/02/2026
    • Carter Gould from Cantor Fitzgerald set a target price of $155.0 on 11/02/2026
    • Chris Schott from JP Morgan set a target price of $175.0 on 10/30/2026
    • Trung Huynh from RBC Capital set a target price of $140.0 on 10/30/2026
    • Vamil Divan from Guggenheim set a target price of $171.0 on 10/30/2026
    • Emily Field from Barclays set a target price of $180.0 on 10/26/2026
    • Geoff Meacham from Citigroup set a target price of $145.0 on 10/12/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles